Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000539770 | SCV000645387 | pathogenic | Griscelli syndrome type 2 | 2018-02-12 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-4 of the RAB27A gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 4 of the RAB27A gene. This is expected to result in an absent or disrupted protein product. Deletion of exons 2-4 of RAB27A has been reported in the literature in an individual affected with hemophagocytic lymphohistiocytosis (PMID: 23160464). Loss-of-function variants in RAB27A are known to be pathogenic (PMID: 10835631, 23160464). For these reasons, this variant has been classified as Pathogenic. |